Alector, Inc.

ALECNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$21.0M

▼ 79.1% YoY

Net Income

-$142.9M

▼ 20.1% YoY

EPS

$-1.39

▼ 13.0% YoY

Cash

$65.8M

▲ 99.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.